(August 25, 2004) -- Boston Scientific Corporation (NYSE: BSX) will webcast a conference call providing updates on its business performance for 2004 and sales of its TAXUS™ Express²™ paclitaxel-eluting coronary stent system. The conference call will take place on Wednesday, September 1, 2004, beginning at 9:00 a.m. ET. The Company plans to issue a press release prior to the call.

The call will be hosted by Jim Tobin, President and Chief Executive Officer, and Larry Best, Senior Vice President and Chief Financial Officer.

The webcast can be accessed at Boston Scientific's website, www.bostonscientific.com. The webcast is also being distributed over CCBN's Investor Distribution Network via two locations: CCBN's Individual Investor Center, www.fulldisclosure.com, which is accessible to the public, and www.streetevents.com, CCBN's password-protected event management site for CCBN clients.

A replay of the webcast will be archived in the Webcast and Archives section of the Investor Relations site at www.bostonscientific.com beginning at approximately 12:00 p.m. ET on September 1 and available for ten business days.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.